...
首页> 外文期刊>Laboratory investigation >FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration
【24h】

FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration

机译:FTY720是一种鞘氨醇1磷酸受体调节剂,它通过抑制细胞因子的产生而不是迁移来抑制CD1d限制的NKT细胞。

获取原文
           

摘要

FTY720, a sphingosine 1-phosphate (S1P) receptor modulator, suppresses immune responses by inhibiting T-cell migration into target tissues; however, it does not alter T-cell functions. In this study, we investigated the biological effects of FTY720 on NKT cells. Unlike T cells, FTY720 suppressed the production of IL-4, IFN-γ, IL-10, and IL-13 by NKT cells through the S1P1 receptor (S1P1). Moreover, FTY720 also inhibited the expression of T-bet and GATA-3 of NKT cells in the presence of TCR engagement. However, it did not inhibit NKT cell migration in vitro or in vivo. In a K/BxN serum transfer arthritis model, FTY720 suppressed arthritis in B6, but not in CD1d?/? mice. Moreover, the adoptive transfer of control NKT cells restored arthritis in CD1d?/? mice, whereas FTY720-pretreated NKT cells did not. The number of NKT cells in the joints of B6 mice given FTY720 was similar to that in the joints of untreated B6 mice, whereas the production of IL-4 and IFN-γ was reduced in the FTY720-treated B6 mice. Taken together, these data show that FTY720 suppresses cytokine production in NKT cells through S1P1, but not NKT cell migration. Thus, FTY720 may be useful in the treatment of NKT cell-promoted immune diseases.
机译:FTY720是一种鞘氨醇1磷酸酯(S1P)受体调节剂,它通过抑制T细胞迁移到靶组织中来抑制免疫反应。但是,它不会改变T细胞功能。在这项研究中,我们调查了FTY720对NKT细胞的生物学作用。与T细胞不同,FTY720抑制NKT细胞通过S1P1受体(S1P1)产生IL-4,IFN-γ,IL-10和IL-13。此外,在存在TCR参与的情况下,FTY720还抑制NKT细胞的T-bet和GATA-3的表达。但是,它在体外或体内均不抑制NKT细胞迁移。在K / BxN血清转移性关节炎模型中,FTY720抑制了B6中的关节炎,但不抑制CD1d3 /α中的关节炎。老鼠。而且,对照NKT细胞的过继转移恢复了CD1d 2 /α中的关节炎。 FTY720预处理的NKT细胞则没有。给予FTY720的B6小鼠关节中的NKT细胞数量与未治疗的B6小鼠的关节中的相似,而经FTY720治疗的B6小鼠中IL-4和IFN-γ的产生减少。综上所述,这些数据表明FTY720通过S1P1抑制NKT细胞中细胞因子的产生,但不抑制NKT细胞的迁移。因此,FTY720可用于治疗NKT细胞促进的免疫疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号